home / stock / nlnk / nlnk news


NLNK News and Press, NewLink Genetics

Stock Information

Company Name: NewLink Genetics
Stock Symbol: NLNK
Market: NASDAQ
Website: lumos-pharma.com

Menu

NLNK NLNK Quote NLNK Short NLNK News NLNK Articles NLNK Message Board
Get NLNK Alerts

News, Short Squeeze, Breakout and More Instantly...

NLNK - Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of NewLink Common Stock

Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of NewLink Common Stock Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of NewLink Common Stock PR Newswire NEW ORLEANS ...

NLNK - Lumos Pharma Appoints Joseph S. McCracken, DVM, MS to Board of Directors Rick Hawkins, CEO, appointed Chairman of the Board

AUSTIN, Texas, March 30, 2020 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, has announced the appointment of Joseph S. McCracken, DVM, MS to the company's Board of Directors, effective March 23...

NLNK - NewLink shareholders back Lumos merger

NewLink Genetics (NASDAQ: NLNK ) shareholders have voted overwhelmingly in favor of its previously announced merger with Lumos Pharma. More news on: NewLink Genetics Corporation, Healthcare stocks news, Merger & acquisition news, Read more ...

NLNK - NewLink Genetics Stockholders Approve Merger with Lumos Pharma

- Combined company, Lumos Pharma, Inc., to trade on Nasdaq under the stock symbol “LUMO” - Phase 2b trial expected to be initiated mid-2020 evaluating oral therapeutic candidate LUM-201 (ibutamoren) in Pediatric Growth Hormone Deficiency (PGHD) - Projected combined cash ...

NLNK - NewLink Genetics EPS beats by $0.06, beats on revenue

NewLink Genetics (NASDAQ: NLNK ): Q4 GAAP EPS of -$0.22 beats by $0.06 . More news on: NewLink Genetics Corporation, Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

NLNK - NewLink Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

AMES, Iowa, Feb. 28, 2020 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced financial results for the fourth quarter and full year ended December 31, 2019, and provided an update on corporate activities. “We continue to focus our work toward the an...

NLNK - Misplaced Assumptions, Where Investments Go Wrong

You've heard the one about the physicist, chemist, and economist marooned on a desert island with a can of beans but no way to open it. With index finger on temple, the physicist opines, "Focus sunlight on the can to melt it." "No", the chemist interrupts, "We should pour saltwater on the li...

NLNK - Stocks To Watch: Key 2020 Events And Catalysts

Welcome to a special New Year's Day edition of Seeking Alpha's Stocks to Watch series - a preview of some key events and catalysts to look for in the new year. A podcast of Stocks to Watch is available every Sunday on Seeking Alpha , Apple Podcasts , Stitcher and Spotify (click the highl...

NLNK - RAD, NIO, FCEL and NLNK among midday movers

Gainers: Savara (NASDAQ: SVRA )  +98% . More news on: Savara Inc., NIO Limited, Sol-Gel Technologies Ltd., Stocks on the move, Read more ...

NLNK - WVE, RAD among premarket losers

Wave Life Sciences (NASDAQ: WVE )  -27%  on disappointing Huntington's data. More news on: Wave Life Sciences Ltd., Iterum Therapeutics plc, NewLink Genetics Corporation, Stocks on the move, Read more ...

Next 10